A Patient-Centered Conceptual Model of Symptoms and Their Impact in Early Parkinson’s Disease: A Qualitative Study

Background: Individuals with Parkinson’s disease (PD) develop a significant disease burden over time that contributes to a progressive decline in health-related quality of life. There is a paucity of qualitative research to understand symptoms and impacts in individuals with early-stage PD (i.e., Ho...

Full description

Saved in:
Bibliographic Details
Published inJournal of Parkinson's disease Vol. 12; no. 1; pp. 137 - 151
Main Authors Staunton, Hannah, Kelly, Kim, Newton, Louise, Leddin, Mathias, Rodriguez-Esteban, Raul, Chaudhuri, K. Ray, Weintraub, Daniel, Postuma, Ronald B., Martinez-Martin, Pablo
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.01.2022
Sage Publications Ltd
IOS Press
Subjects
Online AccessGet full text
ISSN1877-7171
1877-718X
DOI10.3233/JPD-202457

Cover

Abstract Background: Individuals with Parkinson’s disease (PD) develop a significant disease burden over time that contributes to a progressive decline in health-related quality of life. There is a paucity of qualitative research to understand symptoms and impacts in individuals with early-stage PD (i.e., Hoehn and Yahr stage 1–2 and ≤2 years since diagnosis). Objective: The collection of qualitative data to inform the selection of clinical outcome assessments for clinical trials is advocated by regulators. This patient-centered, multistage study sought to create a conceptual model of symptoms and their impact for individuals with early-stage PD. Methods: Symptoms and impacts of PD were gathered from a literature review of qualitative research, a quantitative social media listening analysis, and qualitative patient concept elicitation interviews (n = 35). Clinical experts provided input to validate and finalize the concepts. Results: The final conceptual model consisted of 27 symptoms categorized into ‘motor’ or ‘non-motor’ domains, and 39 impacts divided into five domains. Most frequently reported symptoms in early-stage PD were ‘tremors’ (89%), ‘stiffness and rigidity’, and ‘fatigue’ (69%, both). Most frequently reported impacts included ‘anxiety’ (74%), ‘eating and drinking’ (71%), followed by ‘exercise/sport’ and ‘relationship with family/family life’ (66%, both). Conclusion: This study provides initial insights relating to the symptom and impact burden of early-stage PD patients. The conceptual model can be used to help researchers to develop and select optimal patient-centered outcomes to measure treatment benefit in clinical trials. These findings could inform future qualitative research and the development of outcomes specifically for early-stage PD patients.
AbstractList Background: Individuals with Parkinson’s disease (PD) develop a significant disease burden over time that contributes to a progressive decline in health-related quality of life. There is a paucity of qualitative research to understand symptoms and impacts in individuals with early-stage PD (i.e., Hoehn and Yahr stage 1–2 and ≤2 years since diagnosis). Objective: The collection of qualitative data to inform the selection of clinical outcome assessments for clinical trials is advocated by regulators. This patient-centered, multistage study sought to create a conceptual model of symptoms and their impact for individuals with early-stage PD. Methods: Symptoms and impacts of PD were gathered from a literature review of qualitative research, a quantitative social media listening analysis, and qualitative patient concept elicitation interviews (n = 35). Clinical experts provided input to validate and finalize the concepts. Results: The final conceptual model consisted of 27 symptoms categorized into ‘motor’ or ‘non-motor’ domains, and 39 impacts divided into five domains. Most frequently reported symptoms in early-stage PD were ‘tremors’ (89%), ‘stiffness and rigidity’, and ‘fatigue’ (69%, both). Most frequently reported impacts included ‘anxiety’ (74%), ‘eating and drinking’ (71%), followed by ‘exercise/sport’ and ‘relationship with family/family life’ (66%, both). Conclusion: This study provides initial insights relating to the symptom and impact burden of early-stage PD patients. The conceptual model can be used to help researchers to develop and select optimal patient-centered outcomes to measure treatment benefit in clinical trials. These findings could inform future qualitative research and the development of outcomes specifically for early-stage PD patients.
Background: Individuals with Parkinson’s disease (PD) develop a significant disease burden over time that contributes to a progressive decline in health-related quality of life. There is a paucity of qualitative research to understand symptoms and impacts in individuals with early-stage PD (i.e., Hoehn and Yahr stage 1–2 and ≤2 years since diagnosis). Objective: The collection of qualitative data to inform the selection of clinical outcome assessments for clinical trials is advocated by regulators. This patient-centered, multistage study sought to create a conceptual model of symptoms and their impact for individuals with early-stage PD. Methods: Symptoms and impacts of PD were gathered from a literature review of qualitative research, a quantitative social media listening analysis, and qualitative patient concept elicitation interviews (n = 35). Clinical experts provided input to validate and finalize the concepts. Results: The final conceptual model consisted of 27 symptoms categorized into ‘motor’ or ‘non-motor’ domains, and 39 impacts divided into five domains. Most frequently reported symptoms in early-stage PD were ‘tremors’ (89%), ‘stiffness and rigidity’, and ‘fatigue’ (69%, both). Most frequently reported impacts included ‘anxiety’ (74%), ‘eating and drinking’ (71%), followed by ‘exercise/sport’ and ‘relationship with family/family life’ (66%, both). Conclusion: This study provides initial insights relating to the symptom and impact burden of early-stage PD patients. The conceptual model can be used to help researchers to develop and select optimal patient-centered outcomes to measure treatment benefit in clinical trials. These findings could inform future qualitative research and the development of outcomes specifically for early-stage PD patients.
Individuals with Parkinson's disease (PD) develop a significant disease burden over time that contributes to a progressive decline in health-related quality of life. There is a paucity of qualitative research to understand symptoms and impacts in individuals with early-stage PD (i.e., Hoehn and Yahr stage 1-2 and ≤2 years since diagnosis). The collection of qualitative data to inform the selection of clinical outcome assessments for clinical trials is advocated by regulators. This patient-centered, multistage study sought to create a conceptual model of symptoms and their impact for individuals with early-stage PD. Symptoms and impacts of PD were gathered from a literature review of qualitative research, a quantitative social media listening analysis, and qualitative patient concept elicitation interviews (n = 35). Clinical experts provided input to validate and finalize the concepts. The final conceptual model consisted of 27 symptoms categorized into 'motor' or 'non-motor' domains, and 39 impacts divided into five domains. Most frequently reported symptoms in early-stage PD were 'tremors' (89%), 'stiffness and rigidity', and 'fatigue' (69%, both). Most frequently reported impacts included 'anxiety' (74%), 'eating and drinking' (71%), followed by 'exercise/sport' and 'relationship with family/family life' (66%, both). This study provides initial insights relating to the symptom and impact burden of early-stage PD patients. The conceptual model can be used to help researchers to develop and select optimal patient-centered outcomes to measure treatment benefit in clinical trials. These findings could inform future qualitative research and the development of outcomes specifically for early-stage PD patients.
Author Postuma, Ronald B.
Staunton, Hannah
Leddin, Mathias
Rodriguez-Esteban, Raul
Kelly, Kim
Martinez-Martin, Pablo
Weintraub, Daniel
Newton, Louise
Chaudhuri, K. Ray
Author_xml – sequence: 1
  givenname: Hannah
  surname: Staunton
  fullname: Staunton, Hannah
  email: hannah.staunton@roche.com
  organization: Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED)
– sequence: 2
  givenname: Kim
  surname: Kelly
  fullname: Kelly, Kim
  organization: Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED)
– sequence: 3
  givenname: Louise
  surname: Newton
  fullname: Newton, Louise
  organization: Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED)
– sequence: 4
  givenname: Mathias
  surname: Leddin
  fullname: Leddin, Mathias
  organization: Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED)
– sequence: 5
  givenname: Raul
  surname: Rodriguez-Esteban
  fullname: Rodriguez-Esteban, Raul
  organization: Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED)
– sequence: 6
  givenname: K. Ray
  surname: Chaudhuri
  fullname: Chaudhuri, K. Ray
  organization: Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED)
– sequence: 7
  givenname: Daniel
  surname: Weintraub
  fullname: Weintraub, Daniel
  organization: Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED)
– sequence: 8
  givenname: Ronald B.
  surname: Postuma
  fullname: Postuma, Ronald B.
  organization: Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED)
– sequence: 9
  givenname: Pablo
  surname: Martinez-Martin
  fullname: Martinez-Martin, Pablo
  organization: Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34657850$$D View this record in MEDLINE/PubMed
BookMark eNptkd9OFTEQxhuCEURufADSxAsTk5V2t93u8cLk5ICKwYgBEu6abjsLhd12bbsk587X8PV8EouHfxp60Zmk3_y-6cwLtO68A4ReUfKuKqtq98vRXlGSknGxhjZpI0QhaHO2fp8LuoG2Y7wk-XBa55rnaKNiNRcNJ5sozfGRShZcKhb5ggAGL7zTMKZJ9firN9Bj3-Hj5TAmP0SsnMEnF2ADPhhGpRO2Du-r0C8zJ1xZF737_fNXxHs2gorwHs_x90yyKbtcAz5Ok1m-RM861UfYvo1b6PTj_snic3H47dPBYn5YaFY1qaAgjKlb3hGmGJtxSlvQMxCNEYJobiqhTdu2QjHNcwTTMlEzoeu2FLpsumoLfVhxx6kdwOj8waB6OQY7qLCUXln574uzF_LcX8umYaWoZxnw-hYQ_I8JYpKXfgou9yzLuqS14BXhWbXz2OaefzflLCArgQ4-xgCd1H_n4W9cbS8pkTe7lHmXcrXLXPL2v5I76pPiNytxVOfw0OITyj93Xa1S
CitedBy_id crossref_primary_10_1002_mdc3_70007
crossref_primary_10_3389_fmed_2024_1274688
crossref_primary_10_1002_mdc3_14321
crossref_primary_10_1002_mdc3_14286
crossref_primary_10_1038_s41583_024_00830_0
crossref_primary_10_3233_JPD_230267
crossref_primary_10_3233_JPD_239006
crossref_primary_10_3233_JPD_225122
crossref_primary_10_1007_s00702_024_02796_w
crossref_primary_10_3233_JPD_225068
crossref_primary_10_1038_s41598_024_71555_4
crossref_primary_10_3389_fneur_2023_1260445
crossref_primary_10_1007_s40120_024_00632_7
crossref_primary_10_3233_JPD_230109
crossref_primary_10_1016_j_drudis_2022_01_015
crossref_primary_10_1212_WNL_0000000000208028
crossref_primary_10_1111_scs_13258
crossref_primary_10_1007_s40120_022_00375_3
crossref_primary_10_3389_fnins_2022_1026065
Cites_doi 10.1177/1525822X05279903
10.1212/01.WNL.0000058905.71369.97
10.1016/j.parkreldis.2014.08.002
10.1002/mdc3.12833
10.1111/j.1468-1331.2008.02056.x
10.1016/j.jval.2011.06.014
10.1002/mds.26424
10.1212/01.CPJ.0000437017.29917.c9
10.1016/S0140-6736(14)61393-3
10.1002/cfg.456
10.1002/mds.22384
10.1093/ageing/26.5.353
10.1016/j.parkreldis.2019.04.014
10.1016/j.neubiorev.2016.07.010
10.1007/s12264-012-1050-z
10.1002/mds.22340
10.1007/s10578-020-01051-z
10.3390/ijms17060904
10.1186/s41687-017-0013-6
10.1177/1359105311428537
10.1016/j.jval.2017.11.014
10.1212/WNL.96.15_supplement.2697
10.3233/JPD-202346
10.1586/erp.11.106
ContentType Journal Article
Copyright 2022 – The authors. Published by IOS Press
Copyright IOS Press BV 2022
2022 – The authors. Published by IOS Press 2022
Copyright_xml – notice: 2022 – The authors. Published by IOS Press
– notice: Copyright IOS Press BV 2022
– notice: 2022 – The authors. Published by IOS Press 2022
DBID AFRWT
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
5PM
DOI 10.3233/JPD-202457
DatabaseName Sage Journals GOLD Open Access 2024
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Neurosciences Abstracts
DatabaseTitleList Neurosciences Abstracts
CrossRef

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: AFRWT
  name: Sage Journals GOLD Open Access 2024
  url: http://journals.sagepub.com/
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate H. Staunton et al
EISSN 1877-718X
EndPage 151
ExternalDocumentID PMC8842769
34657850
10_3233_JPD_202457
10.3233_JPD-202457
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
0R~
4.4
53G
ABDBF
ABIVO
ABJNI
ACGFS
ACPQW
ACPRK
ACUHS
ADZMO
AENEX
AFRHK
AFRWT
ALMA_UNASSIGNED_HOLDINGS
EBD
EBS
GROUPED_DOAJ
HZ~
IOS
J8X
MET
MIO
MV1
NGNOM
O9-
SAUOL
SCNPE
SFC
AAYXX
ACHEB
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
H13
5PM
ID FETCH-LOGICAL-c438t-1e7dd6b5f04a449511bec9e78d770c5d37cdbbb7a4c5bbbedb47647c6b27c28f3
IEDL.DBID AFRWT
ISSN 1877-7171
IngestDate Thu Aug 21 14:09:11 EDT 2025
Fri Jul 25 10:04:51 EDT 2025
Thu Jan 02 22:54:26 EST 2025
Tue Jul 01 05:27:01 EDT 2025
Thu Apr 24 23:05:07 EDT 2025
Tue Jun 17 22:27:39 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords symptoms
Impacts
qualitative research
quality of life
social media
Parkinson’s disease
Language English
License This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
https://creativecommons.org/licenses/by-nc/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c438t-1e7dd6b5f04a449511bec9e78d770c5d37cdbbb7a4c5bbbedb47647c6b27c28f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
OpenAccessLink https://journals.sagepub.com/doi/full/10.3233/JPD-202457?utm_source=summon&utm_medium=discovery-provider
PMID 34657850
PQID 2621675305
PQPubID 2046380
PageCount 15
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8842769
proquest_journals_2621675305
pubmed_primary_34657850
crossref_citationtrail_10_3233_JPD_202457
crossref_primary_10_3233_JPD_202457
sage_journals_10_3233_JPD_202457
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-01-01
PublicationDateYYYYMMDD 2022-01-01
PublicationDate_xml – month: 01
  year: 2022
  text: 2022-01-01
  day: 01
PublicationDecade 2020
PublicationPlace London, England
PublicationPlace_xml – name: London, England
– name: Netherlands
– name: London
– name: Nieuwe Hemweg 6B, 1013 BG Amsterdam, The Netherlands
PublicationTitle Journal of Parkinson's disease
PublicationTitleAlternate J Parkinsons Dis
PublicationYear 2022
Publisher SAGE Publications
Sage Publications Ltd
IOS Press
Publisher_xml – name: SAGE Publications
– name: Sage Publications Ltd
– name: IOS Press
References 2009; 24
2017; 1
2013; 3
2019; 6
1997; 26
2015; 30
2015; 386
2008; 14
2006; 18
2012; 17
2011; 14
2016; 17
2012; 12
2018; 21
2021; 96
2021; 52
2001; 47
2014; 20
2021; 11
2019; 64
2008; 23
2005; 6
2012; 28
2008; 15 Suppl 1
2003; 60
2001; 79
2016; 68
10.3233/JPD-202457_ref17
Hurt (10.3233/JPD-202457_ref25) 2019; 64
Merino-Andreu (10.3233/JPD-202457_ref24) 2003; 60
Tison (10.3233/JPD-202457_ref32) 2013; 3
Moustafa (10.3233/JPD-202457_ref2) 2016; 68
Patrick (10.3233/JPD-202457_ref14) 2011; 14
Goetz (10.3233/JPD-202457_ref29) 2008; 23
Willgoss (10.3233/JPD-202457_ref23) 2021; 52
Kalia (10.3233/JPD-202457_ref31) 2015; 386
Sarkar (10.3233/JPD-202457_ref30) 2016; 17
Kandiah (10.3233/JPD-202457_ref27) 2014; 20
World Medical Association (10.3233/JPD-202457_ref18) 2001; 79
Martinez-Martin (10.3233/JPD-202457_ref4) 2012; 12
Deal (10.3233/JPD-202457_ref5) 2019; 6
Port (10.3233/JPD-202457_ref7) 2021; 11
Guest (10.3233/JPD-202457_ref15) 2006; 18
Poewe (10.3233/JPD-202457_ref1) 2008; 15 Suppl 1
Turner-Bowker (10.3233/JPD-202457_ref16) 2018; 21
Xia (10.3233/JPD-202457_ref3) 2012; 28
Milward (10.3233/JPD-202457_ref11) 2005; 6
Hurt (10.3233/JPD-202457_ref6) 2012; 17
Humphrey (10.3233/JPD-202457_ref22) 2017; 1
Kandiah (10.3233/JPD-202457_ref26) 2009; 24
Donatti (10.3233/JPD-202457_ref10) 2008; 14
Jenkinson (10.3233/JPD-202457_ref28) 1997; 26
Postuma (10.3233/JPD-202457_ref13) 2015; 30
Vinikoor-Imler (10.3233/JPD-202457_ref21) 2021; 96
References_xml – volume: 1
  start-page: 9
  year: 2017
  article-title: A comparison of three methods to generate a conceptual understanding of a disease based on the patients’ perspective
  publication-title: J Patient Rep Outcomes
– volume: 26
  start-page: 353
  year: 1997
  end-page: 357
  article-title: The Parkinson’s Disease Questionnaire (PDQ-39): Development and validation of a Parkinson’s disease summary index score
  publication-title: Age Ageing
– volume: 15 Suppl 1
  start-page: 14
  year: 2008
  end-page: 20
  article-title: Non-motor symptoms in Parkinson’s disease
  publication-title: Eur J Neurol
– volume: 14
  start-page: 9
  year: 2008
  end-page: 12
  article-title: The use of conceptual models, conceptual frameworks, and endpoint models to support label claims of treatment benefit using patient reported outcomes
  publication-title: ISPOR Connect
– volume: 6
  start-page: 678
  year: 2019
  end-page: 686
  article-title: The Parkinson’s Disease Activities of Daily Living, Interference, and Dependence Instrument
  publication-title: Mov Disord Clin Pract
– volume: 52
  start-page: 654
  year: 2021
  end-page: 668
  article-title: Measuring what matters to individuals with Angelman syndrome and their families: Development of a patient-centered disease concept model
  publication-title: Child Psychiatry Hum Dev
– volume: 23
  start-page: 2129
  year: 2008
  end-page: 2170
  article-title: Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results
  publication-title: Mov Disord
– volume: 28
  start-page: 39
  year: 2012
  end-page: 48
  article-title: Progression of motor symptoms in Parkinson’s disease
  publication-title: Neurosci Bull
– volume: 14
  start-page: 967
  year: 2011
  end-page: 977
  article-title: Content validity–establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: Part 1–eliciting concepts for a new PRO instrument
  publication-title: Value Health
– volume: 17
  start-page: 904
  year: 2016
  article-title: Neuroprotective and therapeutic strategies against Parkinson’s disease: Recent perspectives
  publication-title: Int J Mol Sci
– volume: 96
  start-page: 2697
  year: 2021
  article-title: Cross-sectional profile of most bothersome problems as reported directly by individuals with Parkinson’s disease (2697)
  publication-title: Neurology
– volume: 60
  start-page: 1553
  year: 2003
  end-page: 1554
  article-title: Unawareness of naps in Parkinson’s disease and in disorders with excessive daytime sleepiness
  publication-title: Neurology
– volume: 11
  start-page: 715
  year: 2021
  end-page: 724
  article-title: People with Parkinson’s disease: What symptoms do they most want to improve and how does this change with disease duration?
  publication-title: J Parkinsons Dis
– volume: 6
  start-page: 67
  year: 2005
  end-page: 71
  article-title: Ontology-based interactive information extraction from scientific abstracts
  publication-title: Comp Funct Genomics
– volume: 20
  start-page: 1145
  year: 2014
  end-page: 1148
  article-title: Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson’s disease
  publication-title: Parkinsonism Relat Disord
– volume: 3
  start-page: 480
  year: 2013
  end-page: 481
  article-title: Standard strategies for diagnosis and treatment of patients with newly diagnosed Parkinson disease: FRANCE
  publication-title: Neurology. Clin Pract
– volume: 17
  start-page: 1076
  year: 2012
  end-page: 1088
  article-title: The relationship of depression and disease stage to patient perceptions of Parkinson’s disease
  publication-title: J Health Psychol
– volume: 30
  start-page: 1591
  year: 2015
  end-page: 1601
  article-title: MDS clinical diagnostic criteria for Parkinson’s disease
  publication-title: Mov Disord
– volume: 21
  start-page: 839
  year: 2018
  end-page: 842
  article-title: Informing a priori sample size estimation in qualitative concept elicitation interview studies for clinical outcome assessment instrument development
  publication-title: Value Health
– volume: 12
  start-page: 221
  year: 2012
  end-page: 230
  article-title: Quality of life and burden in caregivers for patients with Parkinson’s disease: Concepts, assessment and related factors
  publication-title: Expert Rev Pharmacoecon Outcomes Res
– volume: 79
  start-page: 373
  year: 2001
  end-page: 374
  article-title: World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects
  publication-title: Bull World Health Organ
– volume: 47
  start-page: 199
  year: 2001
  end-page: 203
  article-title: ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice
  publication-title: J Postgrad Med
– volume: 386
  start-page: 896
  year: 2015
  end-page: 912
  article-title: Parkinson’s disease
  publication-title: Lancet
– volume: 68
  start-page: 727
  year: 2016
  end-page: 740
  article-title: Motor symptoms in Parkinson’s disease: A unified framework
  publication-title: Neurosci Biobehav Rev
– volume: 64
  start-page: 220
  year: 2019
  end-page: 225
  article-title: Barriers to reporting non-motor symptoms to health-care providers in people with Parkinson’s
  publication-title: Parkinsonism Relat Disord
– volume: 18
  start-page: 59
  year: 2006
  end-page: 82
  article-title: How many interviews are enough? An experiment with data saturation and variability
  publication-title: Field Methods
– volume: 24
  start-page: 605
  year: 2009
  end-page: 608
  article-title: Cognitive decline in early Parkinson’s disease
  publication-title: Mov Disord
– volume: 18
  start-page: 59
  year: 2006
  ident: 10.3233/JPD-202457_ref15
  article-title: How many interviews are enough? An experiment with data saturation and variability
  publication-title: Field Methods
  doi: 10.1177/1525822X05279903
– volume: 60
  start-page: 1553
  year: 2003
  ident: 10.3233/JPD-202457_ref24
  article-title: Unawareness of naps in Parkinson’s disease and in disorders with excessive daytime sleepiness
  publication-title: Neurology
  doi: 10.1212/01.WNL.0000058905.71369.97
– volume: 20
  start-page: 1145
  year: 2014
  ident: 10.3233/JPD-202457_ref27
  article-title: Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson’s disease
  publication-title: Parkinsonism Relat Disord
  doi: 10.1016/j.parkreldis.2014.08.002
– volume: 6
  start-page: 678
  year: 2019
  ident: 10.3233/JPD-202457_ref5
  article-title: The Parkinson’s Disease Activities of Daily Living, Interference, and Dependence Instrument
  publication-title: Mov Disord Clin Pract
  doi: 10.1002/mdc3.12833
– volume: 15 Suppl 1
  start-page: 14
  year: 2008
  ident: 10.3233/JPD-202457_ref1
  article-title: Non-motor symptoms in Parkinson’s disease
  publication-title: Eur J Neurol
  doi: 10.1111/j.1468-1331.2008.02056.x
– volume: 14
  start-page: 967
  year: 2011
  ident: 10.3233/JPD-202457_ref14
  article-title: Content validity–establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: Part 1–eliciting concepts for a new PRO instrument
  publication-title: Value Health
  doi: 10.1016/j.jval.2011.06.014
– volume: 30
  start-page: 1591
  year: 2015
  ident: 10.3233/JPD-202457_ref13
  article-title: MDS clinical diagnostic criteria for Parkinson’s disease
  publication-title: Mov Disord
  doi: 10.1002/mds.26424
– volume: 3
  start-page: 480
  year: 2013
  ident: 10.3233/JPD-202457_ref32
  article-title: Standard strategies for diagnosis and treatment of patients with newly diagnosed Parkinson disease: FRANCE
  publication-title: Neurology. Clin Pract
  doi: 10.1212/01.CPJ.0000437017.29917.c9
– volume: 386
  start-page: 896
  year: 2015
  ident: 10.3233/JPD-202457_ref31
  article-title: Parkinson’s disease
  publication-title: Lancet
  doi: 10.1016/S0140-6736(14)61393-3
– volume: 14
  start-page: 9
  year: 2008
  ident: 10.3233/JPD-202457_ref10
  article-title: The use of conceptual models, conceptual frameworks, and endpoint models to support label claims of treatment benefit using patient reported outcomes
  publication-title: ISPOR Connect
– volume: 6
  start-page: 67
  year: 2005
  ident: 10.3233/JPD-202457_ref11
  article-title: Ontology-based interactive information extraction from scientific abstracts
  publication-title: Comp Funct Genomics
  doi: 10.1002/cfg.456
– volume: 79
  start-page: 373
  year: 2001
  ident: 10.3233/JPD-202457_ref18
  article-title: World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects
  publication-title: Bull World Health Organ
– volume: 24
  start-page: 605
  year: 2009
  ident: 10.3233/JPD-202457_ref26
  article-title: Cognitive decline in early Parkinson’s disease
  publication-title: Mov Disord
  doi: 10.1002/mds.22384
– volume: 26
  start-page: 353
  year: 1997
  ident: 10.3233/JPD-202457_ref28
  article-title: The Parkinson’s Disease Questionnaire (PDQ-39): Development and validation of a Parkinson’s disease summary index score
  publication-title: Age Ageing
  doi: 10.1093/ageing/26.5.353
– volume: 64
  start-page: 220
  year: 2019
  ident: 10.3233/JPD-202457_ref25
  article-title: Barriers to reporting non-motor symptoms to health-care providers in people with Parkinson’s
  publication-title: Parkinsonism Relat Disord
  doi: 10.1016/j.parkreldis.2019.04.014
– volume: 68
  start-page: 727
  year: 2016
  ident: 10.3233/JPD-202457_ref2
  article-title: Motor symptoms in Parkinson’s disease: A unified framework
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/j.neubiorev.2016.07.010
– volume: 28
  start-page: 39
  year: 2012
  ident: 10.3233/JPD-202457_ref3
  article-title: Progression of motor symptoms in Parkinson’s disease
  publication-title: Neurosci Bull
  doi: 10.1007/s12264-012-1050-z
– volume: 23
  start-page: 2129
  year: 2008
  ident: 10.3233/JPD-202457_ref29
  article-title: Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results
  publication-title: Mov Disord
  doi: 10.1002/mds.22340
– volume: 52
  start-page: 654
  year: 2021
  ident: 10.3233/JPD-202457_ref23
  article-title: Measuring what matters to individuals with Angelman syndrome and their families: Development of a patient-centered disease concept model
  publication-title: Child Psychiatry Hum Dev
  doi: 10.1007/s10578-020-01051-z
– ident: 10.3233/JPD-202457_ref17
– volume: 17
  start-page: 904
  year: 2016
  ident: 10.3233/JPD-202457_ref30
  article-title: Neuroprotective and therapeutic strategies against Parkinson’s disease: Recent perspectives
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms17060904
– volume: 1
  start-page: 9
  year: 2017
  ident: 10.3233/JPD-202457_ref22
  article-title: A comparison of three methods to generate a conceptual understanding of a disease based on the patients’ perspective
  publication-title: J Patient Rep Outcomes
  doi: 10.1186/s41687-017-0013-6
– volume: 17
  start-page: 1076
  year: 2012
  ident: 10.3233/JPD-202457_ref6
  article-title: The relationship of depression and disease stage to patient perceptions of Parkinson’s disease
  publication-title: J Health Psychol
  doi: 10.1177/1359105311428537
– volume: 21
  start-page: 839
  year: 2018
  ident: 10.3233/JPD-202457_ref16
  article-title: Informing a priori sample size estimation in qualitative concept elicitation interview studies for clinical outcome assessment instrument development
  publication-title: Value Health
  doi: 10.1016/j.jval.2017.11.014
– volume: 96
  start-page: 2697
  year: 2021
  ident: 10.3233/JPD-202457_ref21
  article-title: Cross-sectional profile of most bothersome problems as reported directly by individuals with Parkinson’s disease (2697)
  publication-title: Neurology
  doi: 10.1212/WNL.96.15_supplement.2697
– volume: 11
  start-page: 715
  year: 2021
  ident: 10.3233/JPD-202457_ref7
  article-title: People with Parkinson’s disease: What symptoms do they most want to improve and how does this change with disease duration?
  publication-title: J Parkinsons Dis
  doi: 10.3233/JPD-202346
– volume: 12
  start-page: 221
  year: 2012
  ident: 10.3233/JPD-202457_ref4
  article-title: Quality of life and burden in caregivers for patients with Parkinson’s disease: Concepts, assessment and related factors
  publication-title: Expert Rev Pharmacoecon Outcomes Res
  doi: 10.1586/erp.11.106
SSID ssj0000516323
Score 2.3745193
Snippet Background: Individuals with Parkinson’s disease (PD) develop a significant disease burden over time that contributes to a progressive decline in...
Background: Individuals with Parkinson’s disease (PD) develop a significant disease burden over time that contributes to a progressive decline in...
Individuals with Parkinson's disease (PD) develop a significant disease burden over time that contributes to a progressive decline in health-related quality of...
SourceID pubmedcentral
proquest
pubmed
crossref
sage
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 137
SubjectTerms Clinical trials
Fatigue
Humans
Literature reviews
Movement disorders
Neurodegenerative diseases
Parkinson Disease - complications
Parkinson Disease - diagnosis
Parkinson's disease
Patient-Centered Care
Patients
Qualitative Research
Quality of Life
Research Report
Title A Patient-Centered Conceptual Model of Symptoms and Their Impact in Early Parkinson’s Disease: A Qualitative Study
URI https://journals.sagepub.com/doi/full/10.3233/JPD-202457
https://www.ncbi.nlm.nih.gov/pubmed/34657850
https://www.proquest.com/docview/2621675305
https://pubmed.ncbi.nlm.nih.gov/PMC8842769
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1fb9MwED9t3QsvCMS_wKgswQsPhsZ24nQvqFupxqRNFXRib5EdJ9qkNZ1o-tC3fQ2-Hp-EOzsplCKRl0jJKbHuzvbd-e53AG8t7pKZGwqOnpfgylQZNyKx3MTCCO1kVXnEm_OL9PRSnV0lV3tw3dXCtBxcvqe0KhyRX6xpdlM0mqa4FFJ-OJuOUbxCJfrjqpnnIc7dtdOgJ3QwvZrTmXZBmZBr3tW17cOB0MlQ9OBgNPnybbaJx6ByptJ3g4szrTl6OXFAM_3rh9v7145Ruptb-UeCmN-zJo_gYWtsslHQjsewV9ZPoBmxaQBT5RTapV6d7CQUL66QmJqj3bJFxb6u53fNYr5kpnZsRucJ7LMvqWQ3NfO4yIxKpn312M_7H0s2Dmc9R2zEAjKHxxRnlKm4fgqXk0-zk1Pe9l7ghZJZw-NSO5fapBooo9CJimMU9rDUmdN6UCRO6sJZa7VRRYL30lmlU6WL1ApdiKySz6BXL-ryBTC0AaWrrFTUbbfE7a8waFNWdEljjYvgXcfRvGiByak_xm2ODgpxP0fu54H7EbzZ0N4FOI5_Uh12gsk7hcpFKmL0jnB9i-B5kNHmE1KlBPoziEBvSW9DQCDc22_qm2sPxp1lSuh0GAEjOf_-3e6oXv6f5BU8EFRe4UM8h9Brvq_K12j0NLaP-no8Pp70W73tw_7F9PwXcqwFcw
linkProvider SAGE Publications
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3NbtQwEB7B9gAXBOIvUGAkuHAwbGzH9nJbtay2pa0q2IreIjtO1EpttmLTQ2-8Bq_HkzC2swvLIpFLDhk50YzjmbHn-wbgjSMvafyIM8q8OJO2MczywjGbc8u1F00TGW8Oj9T0RO6fFqc9jjtgYXoNLt6Fsir6orhY93-34EK83z_eJctyWejbsCWLoTID2BpPPn-drbZWaJ4pERu75UZrRglLnohJ_xpg3RVtxJebZZJ_1HpF9zO5D_f6uBHHydAP4FbdPoRujMeJF5WFXdrQdhN3Eg7xmoRDn7MLnDf45ebyqptfLtC2HmfhaAD3IjoSz1uMFMcY0M8RCPbz-48F7qZjmw84xkSyEenBMRQd3jyCk8nH2c6U9W0UWCWF6Vhea--VK5qhtJLyoTwnu41qbbzWw6rwQlfeOaetrAq6195JraSulOO64qYRj2HQztv6KSCFc8I3TsjQOLcmT1ZZCg-bcAnrrM_g7VKjZdVzjIdWFxcl5RpB-yVpv0zaz-D1SvYqMWv8U2p7aZhyOTdKrnhOiQ4tVRk8STZaDSGkCvw9wwz0mvVWAoFPe_1Je34WebWNkVyrUQYY7Pz7dZtf9ez_Iq_gznR2eFAe7B19eg53eUBNxJ2bbRh0367rFxTLdO5lP3d_AQZS8E0
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3NbtQwEB7BVkJcEBV_oYVaggsHw8Z24iy3VbertkC1gq3oLbLjWK3UZlfd9NAbr8Hr8STM2NmlyyKRSw4ZOdaM7fnxzDcAby1qycINBEfPS3BlfMGNyCw3qTBCO-l9QLz5cpIfnqrjs-ysC11QLUzHwcV7SqvCGYXDmnb33Hna4VJI-eF4MkLpCpXp-7CF_kzR78HWcPz1-3QVXsG1lsvQ3C0ttObotKQRnPSvAdbV0YaNuZkqeSffK6ig8WN41NmObBiFvQ336uYJtEM2idionCK11HqT7cdaxBskpl5nl2zm2bfbq3k7u1ow0zg2pesBdhQqJNlFwwLMMaMK6FAM9uvHzwUbxaubj2zIItBGgAhnlHh4-xROxwfT_UPetVLglZJFy9NaO5fbzPeVUegTpSnKblDrwmndrzIndeWstdqoKsN37azSudJVboWuROHlM-g1s6Z-AQxNOum8lYqa59aozSqDJqKnRxprXALvlhwtqw5nnNpdXJbobxD3S-R-GbmfwJsV7Tyia_yTancpmHK5PkqRixSdHTyuEngeZbQaQqqcMHz6Ceg16a0ICFN7_UtzcR6wtYtCCZ0PEmAk5z-_25zVy_-T7MGDyWhcfj46-bQDDwUVToTgzS702uub-hWaM6193S3d34qk8V0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Patient-Centered+Conceptual+Model+of+Symptoms+and+Their+Impact+in+Early+Parkinson%E2%80%99s+Disease%3A+A+Qualitative+Study&rft.jtitle=Journal+of+Parkinson%27s+disease&rft.au=Staunton%2C+Hannah&rft.au=Kim%2C+Kelly&rft.au=Newton%2C+Louise&rft.au=Leddin%2C+Mathias&rft.date=2022-01-01&rft.pub=Sage+Publications+Ltd&rft.issn=1877-7171&rft.eissn=1877-718X&rft.volume=12&rft.issue=1&rft.spage=137&rft_id=info:doi/10.3233%2FJPD-202457&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1877-7171&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1877-7171&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1877-7171&client=summon